SCOPUS 정보 검색 플랫폼

Volumn 38, Issue 6, 2001, Pages 1342-1348

Omapatrilat versus lisinopril: Efficacy and neurohormonal profile in salt-sensitive hypertensive patients

(12) Campese, Vito M a,j Lasseter, Kenneth C b Ferrario, Carlos M c Smith, William B d Ruddy, Michael C e Grim, Clarence E f Smith, Ronald D g Vargas, Ramon d Habashy, Michael F a Vesterqvist, Ole h Delaney, Carol L h Liao, Wei Chi i

a UNIVERSITY OF SOUTHERN CALIFORNIA (United States)

b Clinical Pharmacology Associates Miami (United States)

c WAKE FOREST SCHOOL OF MEDICINE (United States)

d New Orleans Center for Clinical Research (United States)

e ROBERT WOOD JOHNSON MEDICAL SCHOOL (United States)

f MEDICAL COLLEGE OF WISCONSIN (United States)

g WAKE FOREST UNIVERSITY (United States)

h BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE (United States)

i 206 Carnegie Center (United States)

more..

Author keywords

Lisinopril; Omapatrilat; Salt sensitivity; Vasopeptidase inhibitor

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; LISINOPRIL; NEUROHORMONE; OMAPATRILAT; PLACEBO; PROTEINASE; VASOPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 0035676155 PISSN: 0194911X EISSN: None Source Type: Journal
DOI: 10.1161/hy1201.096569 Document Type: Article

Times cited : (64)

References (22)

1
- 0032430953
- C-type natriuretic peptide: The endothelial component of the natriuretic peptide system
- (1998) J Cardiovasc Pharmacol , vol.32 , Issue.SUPPL. 3
- Chen, H.H.¹

2
- 0028819075
- Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure
- (1995) J Pharmacol Exp Ther , vol.272 , pp. 619-627
- Trippodo, N.C.¹ Panchal, B.C.² Fox, M.³

3
- 0001061909
- Omapatrilat increases plasma concentration of adrenomedullin in salt-sensitive hypertensives
- Abstract A040
- (2000) Am J Hypertens , vol.13 , Issue.PART 2
- Vesterqvist, O.¹ Campese, V.M.² Liao, W.³ Manning, J.A.⁴ Bragat, A.C.⁵ Delaney, C.L.⁶ Ford, N.F.⁷

4
- 0024364093
- Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans
- (1989) Hypertension , vol.13 , Issue.PART 1 , pp. 640-646
- Janssen, W.M.T.¹ De Zeeuw, D.² Van der Hem, G.K.³ De Jong, P.E.⁴

5
- 0031834174
- Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
- (1998) Am Heart J , vol.135 , Issue.PART 1 , pp. 914-923
- Stein, B.C.¹ Levin, R.I.²

6
- 0003388206
- Natriuretic peptides
- Oparil S, Weber MA, eds. Philadelphia, Pa: WB Saunders Co
- (2000) Hypertension: A Companion to Brenner and Rector's The Kidney , pp. 165-176
- Campese, V.M.¹ Widerhorn, A.L.M.²

7
- 0030752349
- Characterisation of neprilysin (EC 3.4.24.11) S2′ subsite
- (1997) FEBS Lett , vol.411 , pp. 140-144
- Dion, N.¹ Cohen, P.² Crine, P.³ Boileau, G.⁴

8
- 0026472670
- Molecular biology and biochemistry of the natriuretic peptide system, II: Natriuretic peptide receptors
- (1992) J Hypertens , vol.10 , pp. 1111-1114
- Nakao, K.¹ Ogawa, Y.² Suga, S.³ Imura, H.⁴

9
- 0028959107
- Potentiation of natriuretic peptides by neutral endopeptidase inhibitors
- (1995) Clin Exp Pharmacol Physiol , vol.22 , pp. 63-69
- Seymour, A.A.¹ Abboa-Offei, B.E.² Smith, P.L.³ Mathers, P.D.⁴ Asaad, M.M.⁵ Rogers, W.L.⁶

10
- 0024401721
- Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072
- (1989) Hypertension , vol.14 , pp. 87-97
- Seymour, A.A.¹ Fennell, S.A.² Swerdel, J.N.³

11
- 0026316250
- Neutral metalloendopeptidase inhibitors as ANF potentiators: Sites and mechanisms of action
- (1991) Can J Physiol Pharmacol , vol.69 , pp. 1628-1635
- Sybertz E.J., Jr.¹ Chiu, P.J.S.² Watkins, R.W.³ Vemulapalli, S.⁴

12
- 0026734608
- Candoxatril, a neutral endopeptidase inhibitor: Efficacy and tolerability in essential hypertension
- (1992) J Hypertens , vol.10 , pp. 607-613
- Bevan, E.G.¹ Connell, J.M.C.² Doyle, J.³ Carmichael, H.A.⁴ Davies, D.L.⁵ Lorimer, A.R.⁶ McInnes, G.T.⁷

13
- 0027269679
- Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension
- (1993) Hypertension , vol.22 , pp. 119-126
- Richards, A.M.¹ Crozier, I.G.² Kosoglou, T.³ Rallings, M.⁴ Espiner, E.A.⁵ Nicholls, M.G.⁶ Yandle, T.G.⁷ Ikram, H.⁸ Frampton, C.⁹

14
- 0033011038
- Vasopeptidase inhibition: A new concept in blood pressure management
- (1999) J Hypertens , vol.17 , Issue.SUPPL. 1
- Burnett J.C., Jr.¹

15
- 0344780862
- A rational approach to the treatment of hypertension in special populations
- (1999) Am Fam Physician , vol.60 , pp. 156-162
- Hall, W.D.¹

16
- 0029820868
- Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension
- (1996) Hypertension , vol.28 , pp. 335-340
- Campese, V.M.¹ Tawadrous, M.² Bigazzi, R.³ Bianchi, S.⁴ Mann, A.S.⁵ Oparil, S.⁶ Raij, L.⁷

17
- 0033059782
- Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects
- (1999) Am J Hypertens , vol.12 , pp. 563-571
- Norton, G.R.¹ Woodiwiss, A.J.² Hartford, C.³ Trifunovic, B.⁴ Middlemost, S.⁵ Lee, A.⁶ Allen, M.J.⁷

18
- 0031955506
- Effects of omapatrilat in low, normal, and high renin experimental hypertension
- (1998) Am J Hypertens , vol.11 , Issue.PART I , pp. 363-372
- Trippodo, N.C.¹ Robl, J.A.² Asaad, M.M.³ Fox, M.⁴ Panchal, B.C.⁵ Schaeffer, T.R.⁶

19
- 0002904225
- Neutral endopeptidase inhibitors and combined inhibitors of neutral endopeptidase and angiotensin-converting enzyme
- van Zwieten PA, Greenlee WJ, eds. Amsterdam, Netherlands: Harwood Academic Publishers
- (1997) Antihypertensive Drugs , pp. 113-212
- Robl, J.A.¹ Trippodo, N.C.² Petrillo, E.W.³

20
- 0001776069
- Antihypertensive efficacy of omapatrilat, a vasopeptidase inhibitor, compared with lisinopril
- Abstract P1.167
- (1999) J Hypertens , vol.17 , Issue.SUPPL. 3
- Neutel, J.¹ Shepherd, A.² Pool, J.³ Levy, E.⁴ Saini, R.⁵ Chang, P.I.⁶

21
- 0011879431
- Definitions and characteristics of sodium sensitivity and blood pressure resistance
- (1986) Hypertension , vol.8 , Issue.PART 2
- Weinberger, M.H.¹ Miller, J.Z.² Luft, F.C.³ Grim, C.E.⁴ Fineberg, N.S.⁵

22
- 0000894990
- Omapatrilat compared with lisinopril in treatment of hypertension as assessed by ambulatory blood pressure monitoring
- Abstract A085
- (2000) Am J Hypertens , vol.13 , Issue.PART 2
- Asmar, R.¹ Fredebohm, W.² Senftleber, I.³ Chang, P.I.⁴ Gressin, V.⁵ Saini, R.K.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.